Evidence map›Paper›PMID 36777845›Full record

ArticleAmerican journal of translational research2023

Expression profiling of circular RNA reveals a potential miR-145-5p sponge function of circ-AFF2 and circ-ASAP1 in renal cell carcinoma.

Ziliang Ji, Ruijing Lu, Tao Wu, Zhong Chen, Zhiqiang Wen, Zhiguang Li, Xichun Zheng, Jinqi Tang, Xiangqiu Chen, Yinggui Yang and 1 more

Abstract read
In one paragraph

Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ziliang JiDepartment of Urology, Shenzhen Hospital of Southern Medical University 1333 Xinhu Road, Shenzhen 518100, Guangdong, China.
Ruijing LuDepartment of Clinical Laboratory, Shenzhen Baoan Women's and Children's Hospital, Jinan University 56 Yulv Road, Shenzhen 518133, Guangdong, China.
Tao WuDepartment of Urology, Shenzhen Hospital of Southern Medical University 1333 Xinhu Road, Shenzhen 518100, Guangdong, China.
Zhong ChenDepartment of Urology, Shenzhen Hospital of Southern Medical University 1333 Xinhu Road, Shenzhen 518100, Guangdong, China.
Zhiqiang WenDepartment of Urology, Shenzhen Hospital of Southern Medical University 1333 Xinhu Road, Shenzhen 518100, Guangdong, China.
Zhiguang LiDepartment of Urology, Shenzhen Hospital of Southern Medical University 1333 Xinhu Road, Shenzhen 518100, Guangdong, China.
Xichun ZhengDepartment of Urology, Shenzhen Hospital of Southern Medical University 1333 Xinhu Road, Shenzhen 518100, Guangdong, China.
Jinqi TangDepartment of Urology, Shenzhen Hospital of Southern Medical University 1333 Xinhu Road, Shenzhen 518100, Guangdong, China.
Xiangqiu ChenDepartment of Urology, Shenzhen Hospital of Southern Medical University 1333 Xinhu Road, Shenzhen 518100, Guangdong, China.
Yinggui YangDepartment of Urology, Shenzhen Hospital of Southern Medical University 1333 Xinhu Road, Shenzhen 518100, Guangdong, China.
Qingyou ZhengDepartment of Urology, Shenzhen Hospital of Southern Medical University 1333 Xinhu Road, Shenzhen 518100, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCircular RNAs (circRNAs) are involved in carcinogenesis, though their expression profile in renal cell carcinoma (RCC) is uncharacterized. The tumor suppressor gene miR-145-5p is expressed in RCC tissues, but its relationship with circRNAs is unknown. Thus, we aimed to identify differentially expressed circRNAs in RCC tissues and to explore the interaction between these circRNAs and miR-145 in the development of RCC.

methodsWe performed high-throughput sequencing and bioinformatics analyses to examine the expression pattern of circRNAs in RCC. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were used to functionally annotate differentially expressed circRNAs. Quantitative real-time polymerase chain reaction (qRT-PCR) was used for sequence verification. Small interfering RNAs were employed to investigate the function and mechanism of circRNAs in RCC. The relationship between miR-145-5p and circRNAs was confirmed using luciferase, RNA immunoprecipitation (RIP), and biotin-coupled probe RNA pull-down assays.

resultsFifty-three circRNAs were significantly and differentially expressed in RCC compared to normal control tissue. Bioinformatic analyses indicated that two significantly upregulated circRNAs, circ-AFF2 and circ-ASAP1, had sequences corresponding to miR-145 response elements. Consistently, the luciferase reporter, RIP, and biotin-coupled probe RNA pull-down assays showed that circ-AFF2 and circ-ASAP1 may repress miR-145 by acting as sponges. circ-AFF2 and circ-ASAP1 were highly expressed in RCC patient-derived tumor samples; their overexpression correlated with poor prognosis and low miR-145 levels. Knockdown of circ-AFF2 or circ-ASAP1 in RCC cell lines inhibited proliferation, underscoring their oncogenic function. A circRNA-miRNA network was constructed for RCC using the differentially expressed circRNAs and projected miRNAs. Candidate genes were verified by RT-qPCR and western blot, indicating that circ-AFF2 and circ-ASAP1 may be connected to RCC proliferation and metastasis.

conclusioncirc-AFF2 and circ-ASAP1 were upregulated in RCC and likely promote tumor progression by sponging miR-145. Therefore, both circRNAs should be investigated further as potential diagnostic and therapeutic targets for RCC.

Indexed as

circ-AFF2circ-ASAP1Circular RNAhigh-throughput sequencingmiR-145-5prenal cell carcinoma

Identifiers

PMID36777845
PMCPMC9908453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.